Sun Pharmaceutical Industries Inc. is recalling 10,548 bottles of Bupropion Hydrochloride Extended-Release (SR) Tablets in 150 mg and 200 mg strengths. The recall was initiated after a customer found a dark, gritty substance inside a bottle, which was later identified as activated carbon that had leaked from a desiccant canister used to keep the medication dry. This recall affects various bottle sizes, including 60, 100, and 500-count containers sold at pharmacies nationwide.
The tablets may be contaminated with gritty carbon particles if the desiccant canister inside the medicine bottle breaks or leaks. While no injuries have been reported, ingesting this foreign material could cause irritation or other health issues.
You have 2 options:
Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ; Manufactured by Sun Pharmaceutical Industries Limited, Gujarat, India. Recall # D-0857-2022.
Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ; Manufactured by Sun Pharmaceutical Industries Limited, Gujarat, India. Recall # D-0858-2022.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.